SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.37-8.4%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (10208)5/27/1999 10:32:00 AM
From: Bluegreen  Read Replies (1) of 17367
 
You stated>>>>>>>>>Seems he ignores the fact that the trial involved Glasgow 12-15 as well as 8-11.My theory.<<<<<
I thought we decided it was even theoretically possible that all could of been ANY G score, ie. all or most could of been near 15. WHY? Because you already had 62 that died before enrollment so why would the others enrolled be that much more healthier G score wise? So would you agree that if most had high G scores that it would still be possible for ALL 34 deaths to be in treatment group? For example if all had high G scores and no Neuprex then could one double 34 for mortality? This is wild speculation on my part. Just my thoughts and opinions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext